Adverse Drug Reactions Clinical Trial
Official title:
Effect of Epstein-Barr Virus on Macrophage M2/M1 Migration and EphA2 Expression in Adverse Drug Reactions
This study aims to investigate the effect of EBV reactivation or EBV reactivation added with dexamethasone(DXM) in patients with adverse drug reactions(CDR) , through evaluating the levels on monocyte, macrophage M2/M1 and cytokines. To investigate whether expression of EBV receptors EphA2 could specifically influence on EBV activation in CDRs. We performed a prospective longitudinal study on the frequencies of Monocyte, Macrophage, M2/M1 and cytokines included IL-4,IL-13,TNF-α,IFN-γ,IFN-β, CXCL9 and CXCL10 after onset of MPE ,SJS/TEN and control groups. PBMCs collected from peripheral blood were cocultured with EBV or EBV with DXM. We next examined whether EBV or EBV with DXM could have a strong impact on the MOs, Mac, M2/M1 and cytokines and which cytokines could be crucial for the interaction between M2/M1 and EBV, by in vitro cocultures. Finally, EphA2 were detected to evaluate reactivation of EBV.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02239237 -
Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
|
||
| Completed |
NCT02191358 -
YouScript IMPACT Registry
|
N/A | |
| Recruiting |
NCT04743544 -
Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy
|
||
| Recruiting |
NCT04547335 -
The Influence of CYP2C19 Polymorphisms on the Safety and Efficacy of Voriconazole
|
||
| Completed |
NCT02378220 -
Pharmacogenetic Testing Among Home Health Patients
|
N/A | |
| Completed |
NCT01467128 -
Adverse Drug Event Prevention Using Structured Pharmacist Review
|
Phase 4 | |
| Completed |
NCT01354730 -
A Pharmacovigilance Study for AdimFlu-S (A/H1N1) Influenza Vaccine in Pregnant Women
|
Phase 4 | |
| Recruiting |
NCT04496024 -
Ofloxacin Concentration-toxicity Relationship in the Elderly
|
N/A | |
| Completed |
NCT02097654 -
Clinical Trial of a New Software ENgine for the Assessment & Optimization of Drug and Non-drug Therapy in Older peRsons
|
N/A | |
| Completed |
NCT01764204 -
Hospital Intensive Monitoring of Adverse Drug Reactions of Qingkailing Injection In The Next Two Years
|
N/A | |
| Completed |
NCT04252326 -
The Knowledge, Attitudes and Practices of Healthcare Workers on Drug Hypersensitivity Reactions in Children
|
N/A | |
| Completed |
NCT04279470 -
Chimeric Antigen Receptor T-cell and Cellular Therapies for the Treatment of cAncer or BLood Diseases: Evaluation of Reporting of Adverse Events
|
||
| Recruiting |
NCT03640884 -
Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study
|
||
| Completed |
NCT02122965 -
The Effect of Medication Review in High-risk Emergency Department Patients
|
N/A | |
| Completed |
NCT01058122 -
Collection, Evaluation and Assessment of Adverse Drug Reactions on the Oncology Ward
|
||
| Recruiting |
NCT04479553 -
Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
|